Literature DB >> 8645583

A non-random deletion in the p53 gene in oral squamous cell carcinoma.

K Nylander1, E B Schildt, M Eriksson, A Magnusson, C Mehle, G Roos.   

Abstract

In a retrospective study of the mutational spectrum of the p53 gene in oral squamous cell carcinoma, 80 primary tumours diagnosed in 1980-90 were included. Using polymerase chain reaction/single strand conformation polymorphism (PCR/SSCP) analysis 47 mutations were found distributed in 39 of the tumours (49%). Unexpectedly, the majority of the mutations (29/47; 62%) were found in exon 8, and at sequencing 17 of them showed a 14 bp deletion in codons 287-292, causing formation of a stop codon and accordingly a truncated protein lacking the C-terminal. The majority of the patients with the 14 bp deletion were women (13/17), and it seemed as though certain potential risk factors for carcinoma of the head and neck were less common in this group.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645583      PMCID: PMC2074479          DOI: 10.1038/bjc.1996.262

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

Authors:  G Shaulsky; N Goldfinger; A Ben-Ze'ev; V Rotter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

3.  Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes.

Authors:  E Sakai; N Tsuchida
Journal:  Oncogene       Date:  1992-05       Impact factor: 9.867

4.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms.

Authors:  P D Jeffrey; S Gorina; N P Pavletich
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

6.  High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

Authors:  J C Ahomadegbe; M Barrois; S Fogel; M L Le Bihan; S Douc-Rasy; P Duvillard; J P Armand; G Riou
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

7.  Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.

Authors:  A Puisieux; S Lim; J Groopman; M Ozturk
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

8.  An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

Authors:  B Vojtĕsek; J Bártek; C A Midgley; D P Lane
Journal:  J Immunol Methods       Date:  1992-07-06       Impact factor: 2.303

9.  Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.

Authors:  D G Brachman; D Graves; E Vokes; M Beckett; D Haraf; A Montag; E Dunphy; R Mick; D Yandell; R R Weichselbaum
Journal:  Cancer Res       Date:  1992-09-01       Impact factor: 12.701

10.  p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.

Authors:  K Nylander; P Nilsson; C Mehle; G Roos
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more
  5 in total

1.  Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.

Authors:  I Cruz; P J F Snijders; V Van Houten; M Vosjan; I Van der Waal; C J L M Meijer
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

2.  Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma.

Authors:  Soichi Iwai; Wataru Katagiri; Chie Kong; Shigeki Amekawa; Mitsuhiro Nakazawa; Yoshiaki Yura
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.553

3.  p53 mutation, but not p53 overexpression, correlates with survival in head and neck squamous cell carcinoma.

Authors:  H Mineta; A Borg; M Dictor; P Wahlberg; J Akervall; J Wennerberg
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

4.  Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.

Authors:  Bin Yan; Xinping Yang; Tin-Lap Lee; Jay Friedman; Jun Tang; Carter Van Waes; Zhong Chen
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

5.  The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer.

Authors:  M Partridge; G Emilion; S Pateromichelakis; R A'Hern; G Lee; E Phillips; J Langdon
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.